化合物 Quinoprazine T61651

Product Introduction
Bioactivity


英文名: Quinoprazine

描述: Quinoprazine, a powerful inhibitor of Vaccinia virus DNA synthesis (IC50 = 10 μM), exhibits notable antimalarial activity against Plasmodium berghei. Additionally, it demonstrates significant antiprion potency, effectively reducing levels of PrPSc [1]-[5].

体外活性: Quinoprazine shows antimalarial action against Plasmodium berghei, the chloroquine-resistant isolate LN-K65 [1]. Quinoprazine blocks Vaccinia Virus infection by inhibiting DNA synthesis [2]. Quinoprazine (IND2118) displays good antiprion potency and inhibits baseline PrP S c with reducing rates of 76% (dividing cells) and 51% (nondividing cells), respectively. Reducing PrP S c levels by >30% is considered to have good antiprion potency [3] [4]. Quinoprazine (IND2118) shows low cytotoxicity with reducing rates of 25% (dividing cells) and 24% (nondividing cells), respectively. Reducing cells <30% is considered to have a safe effect [3] [4].

体内活性: Quinoprazine is a 1-alkyl-4-[4-(heterylamino)phenyl]piperazines derivate, Quinoprazine (0.25 g/kg; i.p.; single dose) suppresses the growth of larvocysts of Echinococcus multilocularis in cotton rats [5]. Quinoprazine (0.2-0.5 g/kg; p.o.; single dose) acts against the adult Hymenolepis nana. Exptl. and cures infected mice radically [5].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

化合物 Quinoprazine T61651信息由TargetMol中国为您提供，如您想了解更多关于化合物 Quinoprazine T61651报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途